Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study

scientific article published on 01 February 2020

Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V26.I5.535
P932PMC publication ID7015718
P698PubMed publication ID32089629

P2093author name stringYu-Feng Wang
Sha-Sha Li
Huan Ma
Hui-Lai Miao
Jia-Yuan Wu
P2860cites workEvaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyondQ29614697
Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single centerQ33597332
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomesQ33987127
Decision curve analysis: a novel method for evaluating prediction modelsQ34581068
The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasmQ35920101
How to build and interpret a nomogram for cancer prognosisQ37103518
Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER databaseQ37269479
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreasQ38017783
European experts consensus statement on cystic tumours of the pancreasQ38082207
Patterns of Recurrence After Resection of IPMN: Who, When, and How?Q38385287
Prognostic models and nomograms for predicting survival of patients with maxillary sinus carcinomasQ38763662
Pancreatic Cyst Disease: A ReviewQ38823844
Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery ConsortiumQ39025112
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreasQ39452846
Selecting optimal surgical procedures for intraductal papillary mucinous neoplasm (IPMN): An analysis based on the Surveillance, Epidemiology, and End Result registry database.Q39583043
Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategiesQ41120771
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreasQ41130771
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markersQ41814979
Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinomaQ43452944
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysisQ43613552
Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.Q45980129
The Impact of Surgeons on the Likelihood of Mastectomy in Breast CancerQ49713019
Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.Q50050497
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical LiteratureQ50096468
My Treatment Approach: Pancreatic CystsQ50176510
American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.Q50575965
Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines?Q55292571
Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential.Q55410325
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled dataQ58119482
Nomograms for estimating survival in patients with liver-only colorectal metastases: A retrospective studyQ58567675
Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: an Analysis of the Surveillance, Epidemiology, and End Results RegistryQ64684593
Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomasQ80269666
Prevalence of Extrapancreatic Malignancies Among Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasQ88715063
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term SurveillanceQ88872713
Application of net reclassification index to non-nested and point-based risk prediction models: a reviewQ89338036
Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumoursQ90783686
Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN)Q91875183
Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysisQ92887540
P433issue5
P304page(s)535-549
P577publication date2020-02-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleNomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
P478volume26

Search more.